Preoperative chemotherapy in non-small-cell lung cancer: nothing new in n2 disease

T. De Pas; U. Pastorino; L. Spaggiari; G. Curigliano; F. de Braud; C. Robertson

Preoperative chemotherapy in non-small-cell lung cancer: nothing new in n2 disease

T. De Pas, U. Pastorino, L. Spaggiari, G. Curigliano, F. de Braud, C. Robertson

Mathematics And Statistics

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

The study was powered to investigate whether there was a difference from 45% to 60% in 2-year survival rates in patients with early-stage NSCLC treated with induction chemotherapy followed by surgery versus a control group of patients receiving primary surgery.

Original language	English
Pages (from-to)	2603-2604
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	20
Issue number	10
Publication status	Published - 15 May 2002

Keywords

preoperative chemotherapy
lung cancer
oncology

Access to Document

Publisher

Cite this

@article{771ad12c7bcd41f0938b5ca0997f8b33,

title = "Preoperative chemotherapy in non-small-cell lung cancer: nothing new in n2 disease",

abstract = "The study was powered to investigate whether there was a difference from 45% to 60% in 2-year survival rates in patients with early-stage NSCLC treated with induction chemotherapy followed by surgery versus a control group of patients receiving primary surgery.",

keywords = "preoperative chemotherapy, lung cancer, oncology",

author = "{De Pas}, T. and U. Pastorino and L. Spaggiari and G. Curigliano and {de Braud}, F. and C. Robertson",

year = "2002",

month = may,

day = "15",

language = "English",

volume = "20",

pages = "2603--2604",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

number = "10",

}

TY - JOUR

T1 - Preoperative chemotherapy in non-small-cell lung cancer: nothing new in n2 disease

AU - De Pas, T.

AU - Pastorino, U.

AU - Spaggiari, L.

AU - Curigliano, G.

AU - de Braud, F.

AU - Robertson, C.

PY - 2002/5/15

Y1 - 2002/5/15

N2 - The study was powered to investigate whether there was a difference from 45% to 60% in 2-year survival rates in patients with early-stage NSCLC treated with induction chemotherapy followed by surgery versus a control group of patients receiving primary surgery.

AB - The study was powered to investigate whether there was a difference from 45% to 60% in 2-year survival rates in patients with early-stage NSCLC treated with induction chemotherapy followed by surgery versus a control group of patients receiving primary surgery.

KW - preoperative chemotherapy

KW - lung cancer

KW - oncology

UR - http://jco.ascopubs.org/

M3 - Article

VL - 20

SP - 2603

EP - 2604

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 10

ER -